Evidence map›Paper›PMID 34185416›Full record

ArticleClinical and translational medicine2021

Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation.

Anet Laanesoo, Egon Urgard, Kapilraj Periyasamy, Martti Laan, Yury A Bochkov, Alar Aab, Nathaniel Magilnick, Margus Pooga, James E Gern, Sebastian L Johnston and 7 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases.Clinical reviews in allergy & immunology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Regulatory role of microRNAs in virus-mediated inflammation.Journal of inflammation (London, England) · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. miR-146a inhibits ovarian tumor growthMolecular therapy oncolytics · 2023
    Article
  14. Article
  15. MiRNA-146a-A Key Player in Immunity and Diseases.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. MicroRNAs in T Cell-Immunotherapy.International journal of molecular sciences · 2022
    Review
  20. Recent miRNA Research in Asthma.Current allergy and asthma reports · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 6 countries.

Anet LaanesooInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.ORCID 0000-0002-3648-1139
Egon UrgardInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Kapilraj PeriyasamyInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Martti LaanInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Yury A BochkovSchool of Medicine and Public Health University of Wisconsin-Madison, Madison, Wisconsin, USA.
Alar AabInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Nathaniel MagilnickDepartment of Molecular and Cellular Biology, Beckman Research Institute of City of Hope National Medical Center, Duarte, California, USA.
Margus PoogaInstitute of Technology, University of Tartu, Tartu, Estonia.
James E GernSchool of Medicine and Public Health University of Wisconsin-Madison, Madison, Wisconsin, USA.
Sebastian L JohnstonNational Heart and Lung Institute, Imperial College London, London, UK.
Jonathan M CoquetDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
Mark P BoldinDepartment of Molecular and Cellular Biology, Beckman Research Institute of City of Hope National Medical Center, Duarte, California, USA.
Jesper WengelNucleic Acid Center, Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, Denmark.
Alan AltrajaDepartment of Pulmonary Medicine, University of Tartu, Tartu, Estonia.
Grazyna BochenekDepartment of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Bogdan JakielaDepartment of Medicine, Jagiellonian University Medical College, Krakow, Poland.
Ana RebaneInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
University of Tartu · EECity Of Hope National Medical Center · USJagiellonian University · PLUniversity of Wisconsin–Madison · USImperial College Healthcare NHS Trust · GBKarolinska Institutet · SETartu University Hospital · EEUniversity of Southern Denmark · DK

Funding

Wisconsin Infant Study Cohort (WISC)U19AI104317 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI James E. Gern, CHRISTINE Marie SEROOGY · 2013 to 2026
$22.5M
Control of B cell development and effector functions by microRNA-142R01AI125615 · NIAID · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI BOLDIN, MARK P · 2016 to 2020
$2.1M
Department of HealthNIAID NIH HHS R01 AI125615NIAID NIH HHS U19 AI104317
6 · The paper itself

Abstract

Rhinovirus (RV) infections are associated with asthma exacerbations. MicroRNA-146a and microRNA-146b (miR-146a/b) are anti-inflammatory miRNAs that suppress signaling through the nuclear factor kappa B (NF-κB) pathway and inhibit pro-inflammatory chemokine production in primary human bronchial epithelial cells (HBECs). In the current study, we aimed to explore whether miR-146a/b could regulate cellular responses to RVs in HBECs and airways during RV-induced asthma exacerbation. We demonstrated that expression of miR-146a/b and pro-inflammatory chemokines was increased in HBECs and mouse airways during RV infection. However, transfection with cell-penetrating peptide (CPP)-miR-146a nanocomplexes before infection with RV significantly reduced the expression of the pro-inflammatory chemokines CCL5, IL-8 and CXCL1, increased interferon-λ production, and attenuated infection with the green fluorescent protein (GFP)-expressing RV-A16 in HBECs. Concordantly, compared to wild-type (wt) mice, Mir146a/b

Indexed as

AdultAllergensAnimalsAsthmaDisease Models, AnimalFemaleHumansHypersensitivityInflammationMaleMiceMicroRNAsPicornaviridae InfectionsRhinovirusTh2 CellsAllergensMicroRNAsMIRN146 microRNA, humanMirn146 microRNA, mouseasthmabronchial epithelial cellhouse dust mitemicroRNAneutrophilsnoncoding RNAviral infection

Identifiers

PMID34185416
PMCPMC8161513
OpenAlexW3172732893

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.